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Abstract 25 
Genetics and neuroscience are two areas of science that pose particular methodological 26 
problems because they involve detecting weak signals (i.e., small effects) in noisy data. In 27 
recent years, increasing numbers of studies have attempted to bridge these disciplines by 28 
looking for genetic factors associated with individual differences in behaviour, cognition and 29 
brain structure or function. However, different methodological approaches to guarding 30 
against false positives have evolved in the two disciplines. To explore methodological issues 31 
affecting neurogenetic studies, we conducted an in-depth analysis of 30 consecutive articles 32 
in 12 top neuroscience journals that reported on genetic associations in non-clinical human 33 
samples. It was often difficult to estimate effect sizes in neuroimaging paradigms. Where 34 
effect sizes could be calculated, the studies reporting the largest effect sizes tended to have 35 
two features: (i) they had the smallest samples, and were generally underpowered to detect 36 
genetic effects; and (ii) they did not fully correct for multiple comparisons. Furthermore, only 37 
a minority of studies used statistical methods for multiple comparisons that took into account 38 
correlations between phenotypes or genotypes, and only nine studies included a replication 39 
sample, or explicitly set out to replicate a prior finding. Finally, presentation of 40 
methodological information was not standardized and was often distributed across Methods 41 
sections and Supplementary Material, making it challenging to assemble basic information 42 
from many studies. Space limits imposed by journals could mean that highly complex 43 
statistical methods were described in only a superficial fashion.  In sum, methods which have 44 
SQING          11th August 2017 
2 
 
become standard in the genetics literature – stringent statistical standards, use of large 45 
samples and replication of findings – are not always adopted when behavioural, cognitive or 46 
neuroimaging phenotypes are used, leading to an increased risk of false positive findings. 47 
Studies need to correct not just for the number of phenotypes collected, but also for number 48 
of genotypes examined, genetic models tested and subsamples investigated. The field would 49 
benefit from more widespread use of methods that take into account correlations between the 50 
factors corrected for, such as spectral decomposition, or permutation approaches. Replication 51 
should become standard practice; this, together with the need for larger sample sizes, will 52 
entail greater emphasis on collaboration between research groups. We conclude with some 53 
specific suggestions for standardized reporting in this area. 54 
 55 
KEYWORDS: Genetics, Neuroscience, Methodology, Reproducibility, Power, Replication, 56 
Sample size, Multiple comparisons, Statistics, Neuroimaging, Effect size, Reporting 57 
guidelines, Sample selection   58 
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Introduction 59 
Studies reporting associations in humans between common genetic variants and brain 60 
structure or function are burgeoning (Bigos, Hariri, & Weinberger, 2016). One reason is the 61 
desire to find ‘endophenotypes’ that provide an intermediate step between genetic variants 62 
and behaviour (Flint & Munafò, 2007); to this end, it is often assumed that brain-based 63 
measures will give stronger associations than observed behaviour because they are closer to 64 
the gene function. Furthermore, it is now cheaper and easier than ever before to genotype 65 
individuals, with many commercial laboratories offering this service, so neuroscientists 66 
interested in pursuing genetic studies need not have their own laboratory facilities to do this. 67 
The ease of undertaking genetic association studies is, however, offset by methodological 68 
problems that arise from the size and complexity of genetic data. As Poldrack et al (2017) 69 
cautioned with regard to neuroimaging data: "the high dimensionality of fMRI data, the 70 
relatively low power of most fMRI studies and the great amount of flexibility in data analysis 71 
contribute to a potentially high degree of false-positive findings''. When genetic approaches 72 
are combined with neuroscience methods, these problems are multiplied. Two issues are of 73 
particular concern. 74 
The first issue is that the field of neuroscience is characterized by low statistical power 75 
(Button et al., 2013) where sample sizes are often too small to reliably detect effects of 76 
interest. Underpowered studies are likely to miss true effects, and where ‘significant’ effects 77 
are found they are more likely to be false positives. Where common variants are associated 78 
with behavioural phenotypes, effect sizes are typically very small; robust associations 79 
identified in genome-wide association studies (GWAS) typically account for less than 0.1% 80 
of phenotypic variance (Flint & Munafò, 2013). These reach genome-wide significance only 81 
when very large samples are used with this method.  If we have a single nucleotide 82 
polymorphism (SNP) where a genetic variant accounts for .1% of variance (i.e., r2 = .001), 83 
and we want to reliably detect an association of that magnitude, simple power calculations 84 
(Champely, 2016) show that we would need a total sample of 780 cases to detect the effect 85 
with 80% power at the .05 level of significance.  If we had 200 participants (100 for each of 86 
two genotypes), then our power to detect this effect would be only 29%. Although it is often 87 
argued that effect sizes for neuroimaging phenotypes may be larger than for behavioural 88 
measures, a recent analysis by Poldrack et al (2017) suggests caution. They found that for a 89 
motor task that gives relatively large and reliable activation changes in the precentral gyrus, 90 
75% of the voxels in that region showed a standardized effect size (Cohen's d) of less than 91 
one, and the median effect size was around .7; for other well-established cognitive tasks, the 92 
median effect sizes for a specified Region of Interest (ROI) ranged from .4 to .7. 93 
Furthermore, these effect sizes reflect within-subjects comparisons of the overall activation of 94 
task vs. baseline: when assessing differences in activation between groups, effect sizes can be 95 
expected to be smaller than this. 96 
The second issue is that problems arise when there is a failure to appreciate that p-values are 97 
only interpretable in the context of a hypothesis-testing study (de Groot, 2014). Our 98 
knowledge is still limited, and many studies in this area are exploratory: insofar as there is a 99 
hypothesis, it is often quite general, namely that there may be a significant association 100 
between one of the genotypes examined and one or more phenotypes. Spurious findings are 101 
likely if there are many possible ways of analysing findings, and the measures or analyses are 102 
determined only after inspecting the data (Vul & Pashler, 2012). This leads to the twin 103 
problems of p-hacking (selecting and modifying analyses until a ‘significant’ p-value is 104 
found) and hypothesizing-after-results-are-known (Kerr, 1998), both of which render p-105 
values meaningless. These practices are common but not easy to detect, although they may be 106 
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suspected when there are numerous p-values just below a ‘significance’ threshold 107 
(Simonsohn, Simmons, & Nelson, 2015), or when the selection of measures or analyses has 108 
no obvious justification. One solution is to adopt a two-stage approach, where an association 109 
observed in an initial exploratory study (the "discovery" sample) is then tested in a more 110 
focused study that aims to replicate the salient findings in a fresh sample (the "replication" 111 
sample). This approach is now common in GWAS, after early association studies were found 112 
to produce numerous false positive findings. Before the advent of GWAS, the majority of 113 
reported associations did not replicate consistently (Sullivan, 2007). Most genetics journals 114 
now require that in order to be published, associations have to be replicated, and researchers 115 
have learned that large samples are needed to obtain adequate statistical power for replication 116 
(Lalouel & Rohrwasser, 2002) because initial reports overestimate true effect size, e.g. 117 
Behavioral Genetics (Hewitt, 2012). However, outside of GWAS, the importance of 118 
adequately powered replication is not always appreciated. As Poldrack et al (2017) noted, 119 
imaging genetics is 'a burgeoning field that has yet to embrace the standards commonly 120 
followed in the broader genetics literature.' 121 
An alternative approach to replication is to perform a statistical correction for the number of 122 
comparisons in an analysis. However, for this to be effective, the adjustment must be made 123 
for the multiplicity of potential analyses at several levels. Consider, for instance, a study 124 
where three SNPs are studied for association with measures of neural connectivity, based on 125 
four brain regions. If the SNPs are in linkage equilibrium (i.e., not associated) and the 126 
connectivity measures are uncorrelated, then it might seem that we could adequately control 127 
type 1 error by using a Bonferroni corrected p-value of .05/(3*4) = .004. However, suppose 128 
the researchers also study connectivity between brain regions, then there are six measures to 129 
consider (AB, AC, AD, BC, BD, CD). They may go on to test two models of genetic 130 
association (dominant and recessive) and further subdivide the sample by gender, increasing 131 
the number of potential comparisons to 3 * 6 * 2 * 2 = 72, and the Bonferroni-corrected p-132 
value to .0007. Furthermore, we cannot compute this probability correctly unless all 133 
conducted tests are reported: if the authors remove reference to SNPs, genetic models, 134 
subgroups or phenotypes that did not yield significant results, then reported p-values will be 135 
misleading. In GWAS the finite search space (essentially the likely number of functional 136 
genetic variants in the human genome, estimated as around one million) means that a p-value 137 
threshold corrected for all possible tests can be calculated – in these studies, genome-wide 138 
significance for a single trait is typically set at 5 x 10-8 (Sham & Purcell, 2014). 139 
Journal editors are becoming aware of problems of reproducibility in the field of 140 
neuroscience (Nicolas, Charbonnier, & Oliveira, 2015), many of which are reminiscent of 141 
earlier problems in the candidate gene era (Flint, Greenspan, & Kendler, 2010). The current 142 
study was designed to evaluate the extent to which these problems currently affect the field of 143 
human neurogenetics, and to identify instances of good practice that might suggest ways of 144 
overcoming the methodological and logical difficulties that researchers in this area face. 145 
 146 
Study protocol 147 
The protocol for this study was registered on Open Science Framework 148 
(https://osf.io/67jwb/). Many modifications were subsequently made in the course of collating 149 
studies for analysis, because papers or reported measures did not readily fit into the 150 
categories we had anticipated. Furthermore, the complexity of the methods used in many 151 
studies was such that it took substantial time to identify basic information such as effect sizes, 152 
which led to us focusing on a more restricted set of study features than we had originally 153 
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planned. In addition, we added Cyril Pernet to the study team as it became clear that we 154 
needed additional expertise in neuroimaging methods to evaluate some of the papers. 155 
Departures from the protocol are noted below, with an explanation of each one.  156 
Electronic search strategy 157 
The search was conducted using the Web of Science database. We started with the 20 most 158 
highly-ranked journals in neuroscience and behaviour (source: 159 
https://www.timeshighereducation.com/news/top-20-journals-in-neuroscience-and-160 
behaviour/412992.article). We then excluded journals that have a wide scope of subject 161 
matter (e.g., Nature, Proceedings of the National Academy of Sciences) and those that focus 162 
on review articles (e.g., Current Opinion in Neurobiology), which left 12 suitable journals to 163 
be used for the literature search. All of these publish articles in English only.  164 
In our protocol, we planned to examine 50 publications, but we had underestimated the 165 
amount of time needed to extract information from papers, many of which were highly 166 
complex. When this became apparent, we decided that our resources would allow us to 167 
examine 30 publications in full, and so we restricted consideration to the most recent papers, 168 
starting with June 2016 and working backwards until 30 suitable papers were selected (initial 169 
search June 2016 – June 2011). 170 
In order to identify relevant articles, the names of the 12 journals were coupled with topic-171 
specific search terms. We limited the search to studies of humans, and used the following key 172 
terms:  173 
(Nature Neuroscience OR Neuron OR Annals of Neurology OR Brain OR Molecular 174 
Psychiatry OR Biological Psychiatry OR Journal of Neuroscience OR Neurology OR Journal 175 
of Cognitive Neuroscience OR Pain OR Cerebral Cortex OR Neurolmage) AND TOPIC: 176 
(genetic OR gene OR allele) AND TOPIC: (association) AND TOPIC: (cognition OR 177 
behaviour OR individual differences OR endophenotype) AND TOPIC: (human) 178 
 179 
Selection criteria and data extraction 180 
The first author screened abstracts found by the electronic search to identify relevant articles. 181 
The first and last author independently coded the first 500 articles and discussed sources of 182 
disagreement. This led to some refinement of the inclusion and exclusion criteria that had 183 
been specified in the original protocol, as described below (see Figure 1). The first 30 articles 184 
that met the final inclusion and exclusion criteria were fully reviewed and meta-data 185 
extracted (see below for details).  186 
  187 
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Figure 1 188 
Flowchart showing stages of article selection 189 
 190 
 191 
Inclusion criteria: 192 
 Candidate gene(s) study  193 
 Studies predominantly focusing on healthy individuals. This includes population-194 
based studies that may include individuals suffering from a disorder but where the 195 
phenotype of interest is a cognitive, behavioural or neuroimaging characteristic. 196 
 197 
Exclusion criteria: 198 
Original exclusion criteria specified in our protocol were: 199 
 Review articles 200 
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 Genome wide association studies 201 
 Studies predominantly focusing on genetic associations where the phenotype is a 202 
disease or disorder (e.g., neurodegenerative disease, neurodevelopmental disorder or 203 
psychiatric disorders) 204 
Additional exclusionary criteria included after assembling pool of potential studies: 205 
 Studies reporting an abstract only  206 
 Studies solely on non-human species 207 
 Studies solely focused on rare variants (i.e., those with a minor allele frequency less 208 
than 1%, or copy-number variants), because our focus was on common variation 209 
rather than disease, and rare variants and copy number variants require a different 210 
analytic approach. 211 
 Studies focused solely on gene expression 212 
 Studies with no molecular genetic content (e.g., twin studies) 213 
 Analyses using polygenic risk scores 214 
Data were extracted for the following characteristics:  215 
1. Information about the study sample: the aim was to record information that made it 216 
possible to judge whether this was a clinical or general population sample, and if 217 
general population, whether a convenience sample or more representative 218 
2. All SNPs that were tested 219 
3. All measures of cognition, behaviour or neurological structure or function that were 220 
used as dependent variables 221 
4. Sample size 222 
5. Analysis method(s) 223 
6. Any results given in terms of means and variance (SD or SE) on dependent measures 224 
in relation to genotype  225 
7. Statistics that could be used to obtain a measure of association (odds ratios, regression 226 
coefficients, p-values, etc).  227 
In our original protocol, we had planned also to evaluate the functionality of polymorphisms, 228 
to look for information on the reliability of phenotypes, and to evaluate the 229 
comprehensiveness of the literature review of each study, but the challenges we experienced 230 
in extracting and interpreting statistical aspects of the main results meant that we did not have 231 
sufficient resources to do this. 232 
The information that we extracted was used to populate an Excel template for each study, 233 
which included information on sample size, corrections for multiple comparisons and 234 
whether or not a replication sample was included. The sample size was used to compute two 235 
indices of statistical power using the pwr package in R (R Core Team, 2016): (i) the effect 236 
size (r) detectable with 80% power; (ii) power of the study to detect an effect size (r) of .1.  237 
We planned also to extract an effect size for each study, indicating the strength of genetic 238 
influence on the phenotype of interest. This proved difficult because many studies reported a 239 
complex range of results, with some including interaction effects as well as main effects of 240 
genotype. In addition, for studies reporting neuroimaging results, large amounts of data with 241 
spatial and temporal dependencies pose considerable challenges when estimating effect sizes, 242 
and so such studies were flagged as they often required alternative approaches. 243 
To make the task of synthesizing evidence more tractable, we identified a ‘selected result’ for 244 
each study. To facilitate comparisons across studies and avoid the need for subjective 245 
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judgement about the importance of different results, we identified this as the genotypic effect 246 
with the largest effect size (excluding any results from non-human species): this means that 247 
our estimates of study power give a 'best case scenario'. It also meant that in our summary 248 
template, study findings were often over-simplified, but we included a ‘comments’ field that 249 
allowed us to describe how this selected result fitted into the fuller context of the study. Our 250 
approach to computing a standard effect size is detailed below in the section on Analytic 251 
Approach. 252 
In a further departure from our original protocol we sent the template for each study to the 253 
first and last authors with a request that they scrutinize it and correct any errors, with a 254 
reminder sent 2-3 weeks later to those who had not responded. Acknowledgement of the 255 
email was obtained from authors of 23 of 30 studies (77%), 19 of whom (63%) provided the 256 
requested information, either confirming the details in the template or making suggestions or 257 
corrections. The latter were taken into consideration in the summary of each study. We 258 
initially referred to the selected result with the largest genetic effect as a 'key result', and 259 
several authors were unhappy with this, as they felt that we should focus on the result of 260 
greatest interest, rather than largest effect size. We dealt with this by rewording and adding 261 
further explanation about other results in the study, noting when the selected result did not 262 
correspond to the author's main focus. 263 
Simulations 264 
We had not planned to include simulations in our protocol, but we found it helpful to write 265 
scripts to simulate data to explore two issues that arose. First, we considered how the false 266 
positive rate was affected when all three models: additive, dominant and recessive, were 267 
tested in the same dataset. Second, we considered how use of a selected sample (e.g., high 268 
ability students) might affect genetic associations when cognitive phenotypes were used. 269 
Data extraction 270 
Effect size: For each study, we aimed to extract an effect size, representing the largest 271 
reported effect of a genotype on a phenotype. For simple behavioural/cognitive phenotypes, it 272 
was usually possible to compute an effect size in terms of the correlation coefficient, r, which 273 
when squared provides the proportion of variance accounted for by genotype. The correlation 274 
coefficient is identical to the regression coefficient, β, when both predicted variable (y = 275 
phenotype of interest) and predictor (x = genotype) are standardized. For a standard additive 276 
genetic model with three genotypes (aa, aA and AA), the number of ‘risk’ alleles is the 277 
independent measure, so the regression tests for a linear increase in phenotypic score from aa 278 
to aA to AA. Where authors reported an unstandardized regression coefficient, b, the 279 
correlation coefficient, r, was obtained by the formula r = b.sx/sy, where sx and sy are the 280 
standard deviation for x (N risk alleles) and y (phenotype).  Formulae from Borenstein et al 281 
(2009) were used to derive values of r when data were reported in terms Cohen’s d, odds 282 
ratios, or means and standard deviations by genotype. Where standard errors were reported, 283 
these were converted to standard deviations by the formula SD = SE*sqrt(N).  284 
Two studies used structural equation modelling of relationships between variables, 285 
demonstrating that model fit was improved when genotype was incorporated in the model. In 286 
these cases, standardized parameter estimates or Pearson correlation coefficients relating 287 
genotype to phenotype were used to provide a direct measure of effect size (r). 288 
 289 
For studies using phenotypic measures based on neuroimaging, an effect size can be 290 
estimated if an average measure of structure (e.g., grey or white matter volume) or function 291 
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(e.g., or blood-oxygen-level dependent [BOLD] response) was taken from a brain region that 292 
was pre-defined in a way that was independent of the genetic contrast. For instance, the focus 293 
may be on a region that gave a significant group difference in a prior study, or the region may 294 
be chosen because it reliably gives strong activation on a task of interest. If several such 295 
regions are identified, then it is necessary to correct for multiple testing (see below), but the 296 
measure can be treated like any other phenotype when computing a standardized effect size, 297 
e.g. using the slope of the regression for three genotype groups in an additive model, to 298 
quantify how much variance in the neuroimaging measure is accounted for by genetic 299 
differences. 300 
 301 
Few neuroimaging studies, however, adopted that approach. More commonly, they reported 302 
peak voxel statistics. This involves a statistical approach of searching for the voxel, or cluster 303 
of voxels, that gives the strongest effect, sometimes in a confined ROI, sometimes over many 304 
brain regions, and sometimes over the whole brain. The search volume can consist of tens or 305 
even hundreds of thousands of voxels. It is well-recognised in this field that correction of 306 
alpha levels needs to be made to control the rate of false positives, and a range of methods 307 
has been developed for this purpose. 1 308 
 309 
Although these methods make it possible to identify patterns of neural structure or function 310 
that differ reliably between groups, it is still not possible to derive a meaningful measure of 311 
effect size. This is because the focus is on just the subset of voxels that reached significance. 312 
As Reddan, Lindquist, & Wager (2017) put it, 'It is like a mediocre golfer who plays 5,000 313 
holes over the course of his career but only reports his 10 best holes. Bias is introduced 314 
because the best performance, selected post hoc, is not representative of expected 315 
performance.' In addition, the extent of the overestimate will depend on study-specific 316 
variables, such as the number of voxels considered and the size of clusters. Estimates of 317 
effects will also be distorted because of spurious dependencies in the data between true 318 
effects and noise (Kriegeskorte, Simmons, Bellgowan, & Baker, 2009). These problems are 319 
compounded by two further considerations. First, groups in genetic analyses are often 320 
unequal in size; where the dependent measure represents peak activation, the group with the 321 
biggest sample size and/or smaller variance in space will have a greater impact on the results. 322 
To continue the golfing analogy, if we compared two golfers on the basis of their best ten 323 
games, and one had played 100 games and the other only 20, then the one with the more 324 
games would look better, even if in fact there was no difference in skill. 325 
It is not uncommon for researchers to use measures of peak activation but treat the resulting 326 
measures like more classic dependent variables (e.g., graphing means and standard errors for 327 
measures of activation across genetic groups, and reporting these along with corrected p-328 
values). Such estimates are inaccurate, and possibly inflated, yet often these are the only kind 329 
of data available. Accordingly, where such approaches were adopted, we used the reported 330 
data to derive a ‘quasi effect size’, deriving r from means and SDs, but we treated these 331 
separately from other effect sizes, as they are likely to be distorted, and it is not possible to 332 
estimate by how much. 333 
 334 
Analytic approach 335 
                                                 
1 For more explanation, see Box 1 on Open Science Framework: osf.io/akuny 
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Our analysis was predominantly descriptive, and involved documenting the methodological 336 
characteristics of the 30 studies. In addition, we considered how effect size related to 337 
statistical power, and the methods used to correct for multiple comparisons. 338 
Results 339 
The genes and phenotypes that were the focus of each study are shown in Appendix 1 and 340 
full summary findings for each of the 30 studies are shown in Appendix 2. These are based 341 
on the templates that were sent to authors of the papers, but they have been modified on the 342 
basis of further scrutiny of the studies. In a preliminary check, we compared these papers to 343 
the set of 548 studies from the Neurosynth database that had been used by Poldrack et al 344 
(2017) to document trends in sample size for neuroimaging papers between 2011 and 2015. 345 
There was no overlap between the two sets. 346 
 347 
Effect size of selected result in relation to sample size 348 
All the studies under consideration reported p-values, but only four explicitly reported 349 
conventional effect sizes (one as Cohen’s d, and three as regression coefficients). Some fMRI 350 
studies mentioned ‘effect size’ or ‘size of effect’ when referring to brain activation, but this 351 
was on an arbitrary scale and therefore difficult to interpret. Nevertheless, we were able to 352 
compute an effect size from reported statistics for all studies that used behavioural (including 353 
cognitive) phenotypes, and quasi effect size (see above) for eight studies using neuroimaging 354 
phenotypes. 355 
As noted, effect sizes of common genetic variants on behavioural or neurological phenotypes 356 
are typically small in magnitude. Where a research literature includes underpowered studies, 357 
effect size may be negatively correlated with sample size, reflecting the fact that small effects 358 
do not reach statistical significance in small samples and tend not to be published.  This effect 359 
was apparent in the 30 papers included in our review. The relevant data are shown in Figure 360 
2, where r is plotted against log sample size. Quasi effect sizes from neuroimaging studies are 361 
likely to be inflated, and so these are shown using different symbols. 362 
 363 
  364 
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Figure 2 365 
Largest obtained effect size in relation to sample size (on log scale) 366 
Quasi effect sizes (see text) shown as unfilled symbols. The red dotted line shows smallest 367 
effect size detectable with 80% power 368 
 369 
 370 
 371 
The correlation between effect size and log sample size is -.85 (bootstrapped 95% CI = -.68 372 
to .94) for the whole sample, and -.77 (bootstrapped 95% CI = -.38 to -.94) when ten 373 
neuroimaging studies with quasi effect sizes are excluded. It is clear from inspection that 374 
effect sizes (r) greater than .3 are seen only in studies where the total sample size is 300 or 375 
less. Only one study with a sample size of 500 or more obtained an effect size greater than .2. 376 
The largest reported effect size mostly clustered around the line corresponding to the effect 377 
detectable with 80% power: this makes sense insofar as studies are published only if they 378 
report statistically significant results. Thus, it is not that smaller studies show larger effects, 379 
but rather than in smaller studies, small effects would not be statistically significant, and so 380 
would tend to go unreported. 381 
 382 
Corrections for multiple comparisons 383 
The need to take multiple comparisons into account appears to be generally recognised: 23 of 384 
the 30 studies (77%) made some mention of this, although they varied widely in how they 385 
handled this issue. We had originally intended to simply report the number and nature of 386 
corrections used for multiple comparisons. However, this too proved complicated because 387 
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there were many ways in which analytic flexibility could be manifest, with multiple 388 
comparison issues arising at several levels: in terms of analysis of subsamples, number of 389 
genetic models, number of polymorphisms, number of phenotypes, and, for neuroimaging 390 
studies, number of brain regions considered. In Table 1 we show for each study the numbers 391 
of comparisons at each level, as well as 'All Comparisons' which is the product of these. 392 
Matters are more complicated when there are dependencies between variables of a given 393 
type, as discussed in more detail below. Furthermore, it could sometimes be difficult to 394 
summarize the information, if certain phenotypes were assessed for just a subset of the 395 
sample, or were ambiguous as to whether they were phenotypes or moderators. In what 396 
follows, we first discuss multiplicity in terms of subgroups, then at genetic and phenotypic 397 
levels, before finally considering multiple comparisons in the context of neuroimaging 398 
studies. 399 
(Table 1 in landscape format is at end of the paper) 400 
Subgroups. In subgroup analysis, the association between genotype and phenotype is 401 
conducted separately for each subgroup (e.g., males and females). Typically, this is in 402 
addition to analysis of the whole sample with all subgroups included. Subgroup analysis is 403 
different from replication, where an association discovered in one sample is then confirmed 404 
in another, independent sample (see below). Most studies did not conduct any subgroup 405 
analysis, but four subdivided the participants by gender, one by ethnic group, one by age 406 
band, and one by psychiatric disorder in relatives.  407 
It is well-known that deciding to analyse subgroups after looking at the data inflates type 1 408 
error (Naggara, Raymond, Guilbert, & Altman, 2011), but there may be good a priori reasons 409 
for distinguishing subgroups. Subsampling by gender is justified where a relevant 410 
polymorphism is located on a sex chromosome, or where there are gender differences in the 411 
phenotype. Subsampling by ethnicity is generally advised to avoid spurious associations 412 
arising because of different proportions of polymorphisms in different ancestral groups (Tang 413 
et al., 2005) - known as population stratification. Nevertheless, subsamples will be smaller 414 
than combined samples, so power of the analysis is reduced, and furthermore each subsample 415 
included in an analysis will increase the likelihood of type 1 error unless the alpha level is 416 
controlled. Only two of the seven studies of subgroups made any adjustment for the number 417 
of subgroups. 418 
Genetic variation. For the genotype part of genotype-phenotype association, there are two 419 
factors to take into account: (a) the number of polymorphisms considered; and (b) the number 420 
of genetic models tested 421 
Number of polymorphisms: Polymorphisms are segments of DNA that take different forms in 422 
different people2. Most studies in our analysis investigated how phenotypes related to 423 
variation in one or more SNPs, with the number of SNPs ranging from one to 192.  424 
Correlation between alleles at two or more genetic loci is referred to as linkage 425 
disequilibrium (LD). This can arise when loci are close together on a chromosome and so not 426 
separated by recombination events during meiosis, or it may be a consequence of population 427 
stratification, e.g., if certain genotypes are correlated with ethnicity or if there is assortative 428 
mating. Genetic variants that are inherited together on the same chromosome (i.e., from the 429 
same parent) give rise to combinations of alleles known as haplotypes. Rather than studying 430 
SNPs, some studies categorized participants according to haplotype status; this involves 431 
                                                 
2 For more explanation, see Box 2 on Open Science Framework: osf.io/akuny 
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looking at the sequence of DNA in longer stretches of DNA, taking parent of origin into 432 
account. 433 
 Where polymorphisms are independent, a Bonferroni correction may be used by simply 434 
dividing the critical p-value by the number of SNPs (Clarke et al, 2011). For polymorphisms 435 
in linkage disequilibrium, the Bonferroni correction is overly-conservative. A range of 436 
methods has been developed to handle this situation and some of these are routinely output 437 
from genetic analysis software. For instance, the dimensionality of the data may be reduced 438 
by spectral decomposition, or by basing analysis on haplotype blocks rather than individual 439 
SNPs: these methods of data reduction are often incorporated as an additional step of 440 
correction for the effective number of comparisons, once the dimensionality had been 441 
reduced. Clarke et al (2011) noted that permutation methods are often regarded as the gold 442 
standard for correcting for multiple testing, but they are computationally intensive. Table 2 443 
shows the different methods encountered in the 13 studies that reported analysis of more than 444 
one polymorphism. It is clear there is wide variation in the types of correction that are used, 445 
and some studies do not report any correction, despite studying two or more independent 446 
genotypes. Furthermore, correlations between polymorphisms were not always reported: in 447 
such cases, it was assumed they were uncorrelated. 448 
Table 2 449 
Correction for multiple testing in relation to genetic variants considered: 13 studies with 2 or 450 
more polymorphisms 451 
 
Correlated* 
Polymorphisms 
Uncorrelated 
Polymorphisms 
No 0 2 
Bonferroni 2 2 
Data 
Reduction** 
3 0 
Permutation 2 1 
 452 
*Treated as correlated if authors reported greater than chance association between SNPs 453 
**e.g. using spectral decomposition to reduce dimensionality of data, or haplotype analysis 454 
 455 
 456 
The majority of studies (N = 17) did not require any correction as only one SNP was 457 
reported. It is, of course, not possible to tell whether researchers tested a larger number of 458 
variants and selectively reported only those that reached statistical significance. A problem 459 
for the field is that it is difficult to detect this practice on the basis of published results. We 460 
know that dropping non-significant findings is a common practice in psychology (John, 461 
Loewenstein, & Prelec, 2012) and we may suspect selective reporting in studies where the 462 
choice of SNP seems arbitrary and unrelated to prior literature. We note below that requiring 463 
authors to report explicitly on whether all conducted tests were reported would ameliorate the 464 
situation. Furthermore, study pre-registration will remove uncertainty about which analyses 465 
were planned.  466 
Eleven of the 13 studies that reported on two or more SNPs corrected for the number of 467 
genotypes tested, though two studies appeared to over-correct, by using a Bonferroni 468 
correction for correlated SNPs. The remaining studies used a range of approaches, some of 469 
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which provided useful examples of how to deal effectively with the issue of multiple testing, 470 
as described further in the Discussion.  471 
Genetic models: Consider a polymorphic SNP, with a major (more common) allele A, and a 472 
minor (less common) allele a, giving three possible genotypes, AA, Aa and aa. Let us suppose 473 
that A is the risk allele (i.e., associated with less optimal phenotype). There are three models 474 
of genetic association that are commonly tested: (i) additive model, tested by assessing the 475 
linear regression of phenotype on number of copies of allele A; (ii) a dominant effect, where 476 
aa differs from AA and Aa, with no difference between the latter two genotypes; and (iii) a 477 
recessive effect, where AA differs from Aa and aa (see Figure 3).  478 
 479 
Figure 3 480 
Schematic of three types of genetic model 481 
 482 
 483 
Some studies considered all three types of model, whereas others tested just one type of 484 
model. In other cases, the comparison was between 2 genotypes that corresponded to groups 485 
identified by length of tandem repeats, rather than base changes, and in one case a 486 
polymorphism on the X chromosome was considered in males, which gave a two-group 487 
comparison (base A vs base G) – because males have only one X chromosome. 488 
There was only one study that explicitly tested three genetic models for each of several SNPs 489 
(additive, dominant, and recessive), and that study included a Bonferroni correction to adjust 490 
for this. This is, in fact, overly-conservative, as the predictions of an additive model partially 491 
overlap with those of recessive and dominant models. We devised a simulation to evaluate 492 
this situation. The phenotype was modelled as a random normal deviate, unrelated to 493 
simulated alleles at two loci for a SNP (A or a), so odds of obtaining a p-value < .05 for any 494 
one analysis should be one in 20.  Regression analyses were run to look for an effect of 495 
number of A alleles (additive model), the effect of AA+Aa vs aa (dominant model), and the 496 
effect of AA vs Aa + aa (recessive model). Results indicated that adequate control for 497 
multiple comparisons is obtained by dividing the p-value by two (Figure 4). One study 498 
focused on interactions between two loci (epistasis) rather than main effects.  Of the 28 499 
remaining studies reporting just one genetic contrast per polymorphism, 17 reported results 500 
from additive genetic models (contrasting those with 0, 1 or 2 copies of an allele), nine 501 
reported only non-additive (dominant or recessive) models, and two included a mixture of 502 
additive and non-additive models, depending on the SNP. Of those reporting non-additive 503 
models, some justified the choice of model by reference to previous studies, but others 504 
grouped together heterozygotes and homozygotes with the minor allele for convenience 505 
because the latter group was too small to stand alone. 506 
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Figure 4 507 
Simulated data showing proportions of significant (p < .05) runs of a simulation that tests 508 
for all three genetic models when null hypothesis is true.  509 
The total region of the pie corresponds to 10% of all runs (i.e., twice the expected 5%, but 510 
lower than the 14% that would be expected if the three models were independent). Note that 511 
we seldom see runs where both dominant and recessive models are significant, because they 512 
lead to opposite patterns of association (Figure 3), but it is not uncommon to see runs where 513 
both additive and recessive, or additive and dominant models are significant. For simulation 514 
code see: osf.io/4dymh. 515 
 516 
Phenotypes. Phenotypes included measures of cognition, behaviour, psychiatric or brain 517 
functioning. For neuroimaging studies, the phenotypes included measures of brain structure 518 
or activation in response to a task. As described more fully below, the neuroimaging literature 519 
has developed particular strategies for dealing with the multiple contrasts issue; in Table 1, 520 
the number of brain regions is ignored when documenting the number of phenotypes. 521 
However, if brain activation was measured in several different tasks, then each task 522 
corresponded to a phenotype as defined for our purposes. 523 
The simplest situation was where a phenotype was assessed using a behavioural or cognitive 524 
test that yielded a single measure, but this type of study was rare. Multiple phenotypic 525 
measures were common. As with genotypes, these were frequently correlated with one 526 
another, making Bonferroni correction too conservative, but studies often failed to report the 527 
extent of correlation between phenotypes. Often multiple measures were used to test the same 528 
construct, and so it is to be expected they would be intercorrelated: in such cases, if no 529 
mention is made of extent of intercorrelation, we record the correlation as 'unclear' in Tables 530 
1 and 3. There was wide variation in the corrections used for the number of phenotypes. No 531 
correction was reported for 11 of 19 studies (58%) that included two or more phenotypes (see 532 
Table 3). In all cases, the phenotypes were correlated (or probably correlated): thus, 533 
conventional Bonferroni correction would have been too stringent. 534 
 535 
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Table 3 536 
Correction for multiple testing in relation to whether behavioural phenotypes are correlated 537 
 NA Correlated 
Probably 
correlated Uncorrelated 
None 0 2 9 0 
Bonferroni 0 1 2 1 
Permutation 0 1 0 2 
Not needed 11 1* 0 0 
*Mendelian randomization method 538 
 539 
Of the four studies using Bonferroni correction, three had correlated phenotypes, but one 540 
(study 9) took into account correlation between variables by reducing the denominator in the 541 
correction, though in what appeared to be an arbitrary fashion. More complex methods using 542 
permutation or bootstrapping were used in only three studies. 543 
 544 
Neuroimaging phenotypes. In neurogenetics, the goal is to find structural or functional 545 
correlates of genotypes. It has long been recognised that neuroimaging poses multiple 546 
comparison problems of its own, since it typically involves gathering information from tens if 547 
not hundreds of thousands of voxels, corresponding to grey or white matter derived variables 548 
in the case of structural imaging (e.g., volume, thickness, anisotropy), or to proxies for 549 
underlying neural activity or connectivity in functional imaging. The spatial and temporal 550 
dependencies between voxels need to be taken into account. 551 
The selection of a region of interest (ROI) is key. The commonest approach is to do a whole 552 
brain analysis. Some studies in our review selected specific regions and some assessed more 553 
than one region: in such cases, it is not sufficient to do statistical adjustments within the 554 
region – one still needs to treat each region as a new phenotype, with further correction 555 
applied to take the potential type I error inflation into account. The numbers for 556 
neuroimaging regions shown in Table 1 refer to the total ROIs that were considered in the 557 
analysis. 558 
For the current analysis, we categorized neuroimaging papers according to whether they used 559 
a ROI specified a priori on the basis of previous research, with activation compared between 560 
genotype groups within that whole region. In such a case, it is possible to compare activation 561 
across genotypes to get a realistic effect size. However, as noted above, where the analysis 562 
involves first finding the voxel or cluster within a ROI that gives peak activation, and then 563 
comparing groups, it is not possible to accurately estimate effect sizes, because the method 564 
will capitalize on chance and so inflate these. Studies that adopted this approach are therefore 565 
flagged in Figure 1 as giving a 'quasi-effect size'.  566 
Replication samples. We had originally intended to classify studies according to whether 567 
they included a replication sample, but this proved inadequate to handle the different 568 
approaches used in our collection of studies. As noted by Clarke et al (2011), a true 569 
replication uses the same SNPs and phenotypes as the original study, but in practice 570 
replication studies often depart from such fidelity and may study nearby variants of the same 571 
gene, or alternative measures of the phenotype. We categorized the replication status of each 572 
study as follows: 573 
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a) Study includes a full replication using comparable genotypes and phenotypes in the 574 
discovery and replication samples. This classification was less straightforward than it may 575 
appear. Consider, for instance, study 1: the replication sample included the same SNPs and 576 
measures from one of the same questionnaires as used in the discovery sample, but with a 577 
slightly different subset of items. In general, we treated a replication as full provided the 578 
measures were closely similar, so a case such as this would be regarded as a full replication. 579 
b) Study includes a partial replication, but with some variation in genotypes or phenotypes in 580 
the discovery and replication samples. 581 
c) Study is a direct replication of a previous study, so no replication sample is needed. 582 
d) Study does not set out to replicate a prior study (though choice of phenotypes and 583 
genotypes is likely to be influenced by prior work) and does not include a replication sample 584 
Even with this classification scheme, categorisation was not always straightforward. For 585 
instance, studies that did not include a replication sample would nevertheless usually aim to 586 
build on prior literature, and might replicate previous findings. These were categorised as 587 
'prior' (option b) only if they were explicitly described as aiming to replicate the earlier work. 588 
We anticipated that replication samples would be more common in journals that regularly 589 
published genetics papers, where the need for replication is part of the research culture. Table 590 
4 shows the number of papers according to replication status and journal.  Note that there 591 
were three journals in our search for which no papers met our inclusion criteria in the time 592 
window we used: Nature Neuroscience, Neuroimage, and Brain. 593 
Table 4 594 
Number of studies including replication sample, by journal 595 
 Yes Partial Prior* No 
Annals Neurol 0 0 0 1 
Biol Psychiat 2 1 0 4 
Cer Cortex 0 0 0 1 
J Cog Neuro 0 1 0 2 
J Neurosci 0 1 0 2 
Mol Psychiat 4 1 2 4 
Neurology 0 0 0 1 
Neuron 0 0 0 1 
Pain 1 0 0 1 
*Study explicitly designed to replicate a prior finding 596 
  597 
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Although the numbers are too small to be convincing, we may note that, in line with 598 
expectations, Molecular Psychiatry, which published the most studies in neurogenetics, was 599 
the journal with the highest proportion of studies including a replication, whereas 600 
neuroscience journals that did not have a genetics focus, and published few genetics studies, 601 
were more likely to publish studies without any replication sample. 602 
Use of selected samples.  603 
Some of the studies that we evaluated used samples from the general population, some used 604 
convenience samples, and some did not clarify how the sample had been recruited. Use of 605 
students has been criticised, on the grounds that people from Western, Educated, 606 
Industrialized, Rich, and Democratic (WEIRD) societies are a very restricted demographic 607 
from which to make generalizations about human behaviour (Henrich, Heine, & Norenzayan, 608 
2010). In the context of genetic research, however, other serious problems arise from the use 609 
of highly selected samples. Quite simply, if the phenotypic scores of a sample cover a 610 
restricted range, then power to detect genetic associations can be seriously affected.  611 
We illustrate this with a simulation of an association between a genetic variant and a 612 
phenotype that has effect size of r = .2 in the general population. Let us assume that the minor 613 
allele frequency is .5, so the ratio of genotypes aa, aA and AA in the general population is 614 
1:2:1. Now suppose we study a sample where everyone is above average on the phenotype, 615 
i.e. we only include those with positive z-scores. As shown in Figure 5, the effect of genotype 616 
on phenotype becomes substantially weaker. If we take an even more extreme group, i.e. the 617 
top third of the population, then the effect is no longer detectable in a moderate-sized sample. 618 
As also shown in Figure 5, as the association between genotype and phenotype decreases 619 
with selection, the ratio of the three genotypes changes, because those with the risk allele are 620 
less likely to be included in the sample. In fact, when there is strong selection, the effect of 621 
genotype will be undetectable, but the frequency of the three genotypes starts to depart 622 
significantly from expected values (see Figure 6). 623 
  624 
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Figure 5 625 
Mean z-scores on a phenotype for three genotypes, when the true association between 626 
genotype and phenotype in the population is r = .2.  627 
Data come from 10 000 runs of a simulation. The left hand panel shows the association in the 628 
full population; the middle panel shows means when the sample is taken only from those in 629 
the top 50% of the population on the phenotype measure, and the right-hand panel shows 630 
results when only the top third of the population is included. Ns are shown above the bars. As 631 
the selection becomes more extreme, the proportions of each genotype start to depart from 632 
the expected 1:2:1 ratio. The script 'simulating genopheno cutoffs.R' is available on: 633 
https://github.com/oscci/SQING_repo 634 
 635 
 636 
A corollary of this effect of sample selection is that moderate effect sizes on highly selected 637 
samples are implausible when the phenotype is related to the criterion for selection. This is 638 
because a moderate effect in a selected group would entail a much larger effect size in the 639 
general population, as well as skewing of the genotype distribution in the selected sample. 640 
Sample selection is therefore crucial. There may be situations when use of student samples is 641 
acceptable, because student status is unrelated to the phenotype of interest. However, where 642 
we are studying cognitive phenotypes, we stack the odds against finding associations with 643 
genotypes if we only study a high-functioning subset of the population. This can pose 644 
problems because, even when efforts are made to recruit a wide range of participants, those 645 
who volunteer tend to be biased towards more affluent and educated people (Rosenthal & 646 
Rosnow, 1975).  647 
  648 
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Figure 6.  649 
Relationship between genotype and phenotype depending on how participants are selected. 650 
The -log10 p-values of the regression coefficient (blck unfilled circles) are shown for the 651 
association between genotype and phenotype for data simulated as in Figure 5, depending on 652 
whether the analysis is done on the whole population or a selected subset. The significance of 653 
the association decreases as the selection becomes stricter. The dotted line shows the log p-654 
value corresponding to p = .05. When there is strong selection (inclusion only of top 33% or 655 
25% of population on a phenotype z-score), there is significant departure from the expected 656 
1:2:1 ratio of genotypes (as tested by chi-square test, red line). 657 
 658 
 659 
Discussion 660 
This in-depth analysis of 30 studies from top neuroscience journals complements other 661 
evaluations of data quality that have used text-mining methods to extract information from 662 
larger datasets. The studies varied widely in methods and phenotypes that were studied, with 663 
some providing good examples of best practice in the field. Nevertheless, we found that when 664 
neuroscience-oriented journals publish studies that include genetic analysis, they often fail to 665 
adopt the same stringent standards for sample size and replication as have become mandatory 666 
in the genetics literature.  667 
 668 
An important limitation of our analysis is that we evaluated only 30 highly heterogeneous 669 
studies; it would not be realistic to assume that the proportion of studies with specific 670 
characteristics is representative of the field as a whole. Nevertheless, even with this small 671 
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sample, it is clear that many genetic studies with neuro or behavioural phenotypes are 672 
underpowered and/or did not correct adequately for multiple testing, even though they were 673 
published in top journals.  674 
Another limitation of our study is that it is based on just one 'selected result' per study, 675 
selected as the genetic association with the largest effect size. Many studies addressed 676 
questions that went beyond simple association between genotype and phenotype. Some 677 
considered the impact of functional groups of genes (e.g., Study 5), or looked at complex 678 
interactions between genetic variants, brain and behaviour phenotypes (e.g., Study 10). A few 679 
complemented studies of humans with animal models (e.g., Study 11). We note that studies 680 
that may look inconclusive when evaluated purely in terms of one selected result can 681 
compensate for this with converging evidence from a range of sources, and our analysis is not 682 
sensitive to this. 683 
Despite this limitation of our approach, our analysis highlighted several issues that may need 684 
to be addressed in order for neurogenetic research to fulfil its promise. 685 
Sample size and power. Sample sizes in this area are often too small to detect likely effects 686 
of genetic variation, particularly when neuroimaging phenotypes are used. A similar issue 687 
was highlighted for neuroimaging studies in general by Poldrack et al (2017), although they 688 
noted that sample sizes are now increasing as awareness of the limitations of small studies is 689 
growing. They concluded that sample sizes need to be justified by an a priori power analysis.  690 
The problem for researchers is that not only is power analysis complicated in neuroimaging 691 
(Mumford & Nichols, 2008), but also that these studies are difficult and time-consuming to 692 
conduct, and recruitment of suitable samples can take months if not years.  However, 693 
Poldrack et al (2017) argued: 'We do not believe that the solution is to admit weakly powered 694 
studies simply on the basis that the researchers lacked the resources to use a larger sample.' 695 
Instead, they recommend that, following the example of the field of genetics, researchers 696 
need to start working together in large consortia, so that adequate power can be achieved. A 697 
complementary approach is to pre-register a study, so that hypotheses, methods and analytic 698 
strategy are decided, and are publicly registered, before the data are collected; this can be 699 
invaluable in guarding against publication bias and the dangers of a flexible analytic pipeline. 700 
Some journals now offer Registered Reports, an approach where publication of a pre-701 
registered study is offered, conditional on satisfactory reviews and adherence to the pre-702 
registered protocol (Chambers, 2013).    703 
 704 
An optimistic interpretation of the data in Figure 2 is that larger effect sizes are seen in 705 
smaller studies because these are studies that use highly specific measures of the phenotype 706 
that are not feasible with large samples. In particular, there is a widespread belief that 707 
neuroimaging will show stronger genetic effects than behavioural measures because it is 708 
closer to the mechanism of gene action. However, a more pessimistic interpretation is that 709 
where large effect sizes are seen in neuroimaging studies these are likely to be false 710 
discoveries arising from the use of small sample sizes with a very flexible analytic pipeline, 711 
and methods that tend to overestimate effect sizes.  712 
 713 
Calculation of effect size. Our analysis highlighted another problem inherent in 714 
neuroimaging studies: the difficulty of specifying effect sizes. Lakens (2013) noted that effect 715 
size computations are not only crucial for establishing the magnitude of reported effects, but 716 
also for creating a literature that is useful for future researchers, by providing data in a format 717 
that can be combined with other studies in a meta-analysis, or which can be used to guide 718 
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power calculations for future studies. Yet in neuroimaging, this is not standard. Indeed, only 719 
three of the 30 studies that we included explicitly mentioned effect sizes with a conventional 720 
interpretation of that term. This is consistent with a systematic review by Guo et al (2014) 721 
who found that only 8 of 100 neuroimaging studies reported effect sizes. When reported, 722 
effect sizes are typically shown for regions with the strongest effects and/or at the maximum 723 
voxel, leading to biased estimates. Correcting for multiple comparisons analyses further 724 
distorts these estimates, as the strongest voxels will be those with ‘favourable’ noise (i.e., 725 
spurious activity that adds to a true effect). 726 
Correction for multiple comparisons. Most studies considered the issue of correction for 727 
multiple comparisons, but few fully corrected for all the tests conducted, taking into account 728 
the number of subgroups, genetic models, polymorphisms and phenotypes. Researchers 729 
appear to be aware of the multiple testing problem but there is not one good solution, and the 730 
impression was that sometimes authors thought they had done enough by applying standard 731 
corrections for fMRI, and did not need to correct for other aspects of the study. For instance, 732 
studies looking at correlations between genotypes or phenotypes in ROI, would have multiple 733 
comparisons procedures for whole brain analyses, but would either compute correlations for 734 
each ROI with no control, or conversely adopt a Bonferroni correction (which controls 735 
exactly the type one error rate) which is known to be is over-conservative .  736 
In the field of genetics, a range of approaches has been developed for assessing associations 737 
when polymorphisms are not independent (i.e., in linkage disequilibrium); some of these, 738 
such as methods of data reduction by spectral decomposition or permutation tests, could be 739 
more widely applied (Clarke et al., 2011). For instance, extraction of latent factors from 740 
correlated phenotypes would provide a more sensitive approach for identifying genetic 741 
associations where a range of measures is used to index a particular construct, such as anxiety 742 
or memory. 743 
Replication. Few studies included an independent replication sample, explicitly separating 744 
out the discovery and replication phases. This approach is now standard in GWAS, and has 745 
contributed to the improved reproducibility of findings in that literature. In principle this is a 746 
straightforward solution. In practice, however, it requires additional resources and means that 747 
studies take longer to complete. It also raises the possibility that findings in the discovery 748 
phase will not be replicated, in which case the overall results may be ambiguous. One 749 
solution to this problem is to apply a more stringent alpha level at the discovery phase than at 750 
the replication phase, and also to present results meta-analysed across both phases (Lander & 751 
Kruglyak, 1995). However, power calculations need to take into account the "winner's curse" 752 
phenomenon, which refers to the upward biasing of effect sizes when an original association 753 
emerged from a study considering many variants (Sham & Purcell, 2014). 754 
Completeness of reporting. An unexpected feature of many of the studies that we analysed 755 
was the difficulty of finding the methodological information that we required from the 756 
published papers. Because there is no standard format for reporting methods, it could be 757 
difficult to know whether specific information (e.g., whether phenotypes were correlated) 758 
was simply omitted, or whether it might be found in Supplementary Material or figure 759 
legends, rather than the Methods section. Consequently, we had to read studies many times to 760 
find key information.  761 
Most of the journals that we included had stringent length limits, or page charges, which 762 
might make it difficult for authors to report all key information. Exceptions were 763 
Neuroimage, Journal of Neuroscience, Pain and Neuron. It is noteworthy that in 2016 Neuron 764 
introduced new guidelines for Structured, Transparent, Accessible Reporting (STAR), and 765 
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removed any length limit on Methods (http://www.cell.com/star-methods), with the goal of 766 
improving reproducibility of published studies.  767 
Complexity of analyses. Several studies used complex analytic methods that were difficult 768 
to evaluate, despite the range of disciplinary expertise covered by the co-authors of our study. 769 
This in itself is potentially problematic for the field, because it means that reviewers will 770 
either decline to evaluate all or part of a study, or will have to take analyses on trust. One 771 
solution would be for journals to require researchers to make available all analysis scripts as 772 
well as raw data, so that others could work through the analysis.  773 
Further considerations. We briefly mention here two additional issues that we were not able 774 
to evaluate systematically in the 30 papers that we considered, but are relevant for future 775 
research in this area. 776 
i)  Validity of genotype-phenotype association. We can be most confident that an association 777 
is meaningful if the genetic variant has been shown to be functional, with physiological 778 
effects that relate to the phenotype. Nevertheless, the ease of demonstrating functionality is 779 
much greater for some classes of variants than others. Furthermore, an association between a 780 
SNP and phenotype does not mean that we have found a functional polymorphism.  781 
Associated SNPs often lie outside genes and may be associated with phenotypes only because 782 
they are close to relevant functional variants – what has been referred to as 'indirect 783 
genotyping' (Clarke et al., 2011). Information about such variants can be valuable in 784 
providing landmarks to the key functional variant. With indirect genotyping, patterns of 785 
association may vary depending on samples, because different samples may have different 786 
patterns of linkage disequilibrium between genes and markers. It follows that a failure to 787 
replicate does not necessarily mean we have a false positive.  788 
ii) Reliability and heritability of phenotypes. The phenotypes that are used in genetic 789 
association studies are increasingly diverse (Flint & Munafò, 2013). The idea behind the 790 
endophenotype concept is that a brain-based measure will be a more valid measure of the 791 
phenotypic effect of a genetic variant than other types of measure, because it is a more direct 792 
indicator of a biological effect. However, evidence for this assumption is lacking, and the 793 
strength of effects will depend on reliability as well as validity of phenotype measures. Quite 794 
simply, if a measure varies from one occasion of measurement to another, it is much harder to 795 
detect group differences even if they are real, because there will be noise masking the true 796 
effects. Therefore, it is advisable before embarking on a genetic association study to optimize 797 
– or at least assess - reliability of phenotypic measures. Psychometric tests typically are 798 
designed to take this into account and data on reliability will be available, but for most 799 
experimental and behavioural measures this is not the case. Furthermore, indices from 800 
functional imaging can vary from time to time (Nord, Gray, Charpentier, Robinson, & Roiser, 801 
2017), and even structural imaging indices are far from perfectly reliable.  Further problems 802 
occur when applying methods such as fMRI to the study of individual differences where 803 
people may differ in brain structure or trivial factors such as movement in the scanner, 804 
masking meaningful individual variation (Dubois & Adolphs, 2016). 805 
As noted by Carter et al (2016) neurogenetic studies rely on the assumption that the 806 
phenotype is heritable. Yet, for many of the phenotypes studied in this field, evidence is 807 
lacking – usually because there are no twin studies using that specific phenotype. Heritability 808 
will be limited by reliability: a measure that shows substantial variation within the same 809 
person from one occasion to the next will not show good agreement between genetically 810 
related individuals.   811 
Proposed reporting requirements for future articles 812 
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We conclude by making some suggestions that will make it easier for future researchers to 813 
understand neurogenetic studies and to combine these in meta-analyses, as detailed in Table 814 
5. Ultimately, this field may need more formal reporting guidelines of the kind that have been 815 
designed to improve reproducibility of research in other areas, such as the guidelines for life 816 
sciences research introduced by Nature journals in 2015 (Nature Publishing Group, 2015), 817 
and the COBIDAS guidelines for MRI (Nichols et al., 2016).  Making formal 818 
recommendations is beyond the scope of this article, but we suggest that if authors 819 
systematically reported this basic information in the Methods section of papers, it would be a 820 
major step forward.  821 
Table 5: Key information for neurogenetic studies 822 
 823 
Sample 824 
 Provide a power calculation to determine the sample size. The usual recommendation 825 
is for 80% power based on estimated effect size, which may be based on results with 826 
this genetic variant in previous studies. If no prior effect size available, it is advisable 827 
to compute power with effect size no greater than r = .2, as few common genetic 828 
variants have effects larger than this. For neuroimaging studies, the application 829 
Neuropower (Durnez, Degryse, Seurinck, Moerkerke, & Nichols, 2015) is a user-830 
friendly toolbox to help researchers determine the optimal sample size from a pilot 831 
study. 832 
 Give total sample size. Where different numbers are involved at different points in a 833 
study, a flowchart is helpful in clarifying the numbers and reasons for exclusions. 834 
 State how the sample was recruited, and whether they are representative of the general 835 
population for the phenotype of interest 836 
Genetic variants 837 
 State how many genetic variants were considered in the analysis  838 
 List all genetic variants, regardless of whether they gave significant results 839 
 Give background information indicating what is known about the genetic variants, 840 
what is known about the minor allele frequency, and whether they are functional. 841 
 State whether or not the genetic variants are in linkage disequilibrium, and if so, how 842 
this is handled in the analysis 843 
 State which genetic models were tested, and where genotypes are combined, whether 844 
this was to achieve a workable sample size, or whether the decision was based on 845 
prior research 846 
Phenotypes 847 
 State whether phenotypes are known to be heritable (e.g. using evidence from twin 848 
studies). 849 
 Provide information on the test-retest reliability of the phenotype 850 
 State whether phenotypes are inter-correlated 851 
 Neuroimaging phenotypes involved many technical choices affecting the processing 852 
pipeline. Guidelines for reporting details of neuroimaging studies have been 853 
developed with the hope of improving reproducibility. The details of analytic 854 
information go beyond the scope of this paper, but useful information is given in Box 855 
4 from Poldrack et al (Poldrack et al., 2017) 856 
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Analysis 857 
 State which analyses were planned in advance. Post hoc analyses can be useful, but 858 
only if they are clearly distinguished from a priori hypothesis-testing analysis. Where 859 
there is a clear a priori hypothesis, consider pre-registering the study 860 
 Describe the total number of independent tests that are conducted on the data. 861 
Describe the approach used to deal with multiple comparisons, bearing in mind that 862 
other approaches exist in cases where a Bonferroni correction is likely to be 863 
overconservative.  864 
 Make scripts for processing the data openly available on a site such as Github or Open 865 
Science Framework. It is common for authors to describe complex methods that are 866 
hard even for experts to understand. By making scripts accessible, authors not only 867 
make their paper easier to evaluate, but they can also serve a useful training function, 868 
and facilitate replication 869 
Results 870 
 Do not rely solely on reporting derived statistics and p-values 871 
 Show measures of central tendency and variation for each genotype group in relation 872 
to each phenotype, together with the effect size, where it is possible to compute this. 873 
Where the phenotype is categorical, report the proportions of people with each 874 
genotype who are in each category 875 
  876 
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Table 1 1007 
Corrections for multiple comparisons in relation to N subgroups, genetic models, polymorphisms, and imaging regions.  1008 
All combinations is the product of all of these. – denotes correlated variables; ~ denotes probably correlated 1009 
Study Subgroups Models Polymorphisms Phenotypes 
Imaging 
regions 
All 
Combinations Correction method 
Full 
correction 
1 2 8 2- 4~ 0 128 Bonferroni correction for 8 SNPs x 
4 measures of phenotype x 2 
genders. 
Partial 
2 1 3 1 5- 0 15 SEM with bootstrapping Partial 
3 1 2- 1 7~ 0 14 None reported No 
4 2 1 1 7~ 2 28 Imaging data FWE corrected, but 
no further correction reported for 
N overall analyses 
No 
5 2 50- 3- 1 0 300 Bonferroni separately for AA & EA 
ethnic groups; significance 
threshold for AA = 1.13 × 10-4 for 
49 variants, 3 genetic models & 3 
phenotypes; for EA=1.09 × 10-4 for 
51 variants, 3 genetic models & 3 
phenotypes) 
Partial 
6 1 1 1 1 2 2 Cluster-wise RFT for imaging data. 
No other corrections reported 
No 
7 1 9- 1 5- 0 45 Initial test of association of 
variants with categorical pain 
phenotype corrected using 
spectral decomposition 
Partial 
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8 1 9 1 10- 0 90 P < .05 with no correction given 
strong prior evidence for all 
hypotheses 
No 
9 1 1 1 14- 0 14 P value of 0.01 was used instead of 
0.05 to balance the risk of type I 
and type II errors, 
Partial 
10 1 1 1 19~ 4 76 Separate Bonferronis: α level of 
.0055 for internal state analyses (9 
time points); α level of .005 for 
perceptual ratings data (5 
perceptual qualities for 2 types of 
stimuli) 
Partial 
11 1 1 1 1 3 3 None reported No 
12 1 36 1 1 0 36 36 SNPs captured the common 
haplotypic diversity of the TREM 
region: locus-wide Bonferroni-
corrected p < 1.4 x 10-3; where 
genetic variant significantly 
associated with NP pathology, 
tested association with 5 
secondary phenotypes, using 
Bonferroni-corrected p < 0.01 
No 
13 1 1 1 15~ 0 15 None reported No 
14 3 1 1 1 3 9 Significance threshold was set to p 
.05, family-wise error corrected for 
multiple comparisons within our a 
priori defined anatomic regions of 
Partial 
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interest (FWEROI), the 
hippocampus and the pgACC. 
15 1 1 1 1 156 156 Sidak corrected significance level 
to maintain α = .05 for testing 156 
correlated outcomes (mean 
correlation ρ = .25) was 
determined at p < 1.14 × 10−3 
Yes 
16 1 1 1 2- 0 2 Not needed; single polymorphism 
to test causal model using 
Mendelian randomisation 
Yes 
17 1 107- 1 2 0 214 Single step Monte Carlo 
permutation method 
Yes 
18 1 23- 1 4 4 368 Gene-wide significance was 
empirically determined with 
permutations that corrected for 23 
SNPs (accounting for their LD 
structure), 4 ROIs, and the number 
of tests (main effects of SNPs, G×E 
interactions). 
Yes 
19 1 93- 1 1 0 93 No correction for multiple testing 
in initial sample because analysis 
conducted for discovery purposes. 
No 
20 1 1 1 14~ 6 84 None reported No 
21 1 1 1 1 64 64 FDR-corrected p values for effect 
of APOE after adjusting for age, 
sex, and amyloid load (all ns) 
Yes 
22 1 10- 1 1 5 50 Significance level of 0.005 
(0.05/10; Bonferroni corrected for 
Partial 
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the number of genetic tests 
conducted); No correction for 
number of ROIs 
23 2 1 1 7~ 4 56 None reported No 
24 1 2 4- 1 1 8 None reported No 
25 1 1 1 1 1 1 Different for ROI and whole-brain; 
latter used fMRI significance 
measured at p < 0.05 family-wise 
error (FWE) corrected for multiple 
comparisons at the voxel level 
Yes 
26 1 2 1 3~ 0 6 P < .05, with Bonferroni correction 
where appropriate. No Bonferroni 
for control analyses. 
Yes 
27 1 1 1 3~ 0 3 Authors reply to query: "We did 
not correct for multiple testing as 
we only assayed 5-HTTLPR" 
No 
28 2 1 1 2~ 4 16 Permutations with 100,000 
iterations to control for 
hemisphere specific tests of VS 
BOLD response 
Partial 
29 1 1 1 10~ 4 40 None reported No 
30 2 1 1 10 0 20 P-values adjusted for N 
inheritance modes. Considering 
the inter-correlation of 9 
measures, reported nominal levels 
of significance. Bonferroni 
correction for 32 tests gave 
significance level of P=0.0016 
Yes 
1010 
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